BioSyent is poised for a great 2015, says Cantor Fitzgerald Canada

Biosyent's leading brand is FeraMAX. It currently markets two formulations for the treatment of iron deficient anemia.

Investors should take advantage of recent softness in shares of BioSyent (TSXV:RX), says Cantor Fitzgerald Canada analyst Scott Curtis. Yesterday, BioSyent reported its fourth quarter and fiscal 2014 results. For the year, the company earned $3.15-million on revenue of $12.21-million, a topline that was up 57% year-over-year. “Two thousand fourteen marked our fifth consecutive year […]

Intertain Group gets price target raise at Mackie

jackpotjoy

Intertain Group (TSX:IT) still has big upside, says Mackie Research Capital analyst Nikhil Thadani. This morning, Intertain announced it had closed its previously announced subscription receipts offering. The company sold a total of 32.2-million subscription receipts at $15 each for aggregate gross proceeds of $483-million. The proceeds of the offering will be used to finance, […]

Kinaxis still has meaningful upside, says Cormark

kinaxis2

Kinaxis (TSX:KXS) has nearly doubled since its IPO, but the stock still has big upside, says Cormark analyst Richard Tse. Yesterday, Kinaxis reported its fourth quarter and fiscal 2014 results. In Q4, the company posted Adjusted EBITDA of $3.8-million on revenue of $18.8-million, in line with Tse’s expectations. “In 2014, we delivered on our goal […]

Constellation Software will struggle to justify heady valuation, says Euro Pacific

It's been a tremendous run for Consteallation Software, but analyst Andrej Krneta thinks the company may be getting toppy, valuation wise.

Constellation Software’s (TSX:CSU) growth through acquisition strategy has made it one of the great successes of Canadian tech, but the company’s top line growth is set to stall, says Euro Pacific analyst Andrej Krneta. Constellation will report its Q4 and fiscal 2014 results today after market close. Krneta expects Constellation will deliver 4.1% quarter-over-quarter top […]

Computer Sciences Corporation acquisition could make sense for CGI, says Cormark

computer-sciences-corp

While he says has no information about a deal being imminent, Cormark analyst Richard Tse says the acquisition of Computer Sciences Corporation’s commercial businesses “could be compelling” for CGI Group (TSX:GIB.A, NYSE:GIB). Yesterday, shares of both CGI and CSC were up sharply on rumours that the latter was looking to split and then sell off […]

Mood Media is undervalued, says Euro Pacific’s Goff

mood media

Mood Media’s (TSX:MM) evolving turnaround will become more evident with the release of its fourth quarter numbers, say Euro Pacific analyst Rob Goff. On March 13th, Mood Media will report its fourth quarter and fiscal 2014 results. Goff expects the company will generate EBITDA of $28.4-million on revenue of $127.9-million. While shares of the company […]

TECSYS could double or triple, says Cantor Fitzgerald

TECSYS CEO Peter Brereton.

If the company keeps winning business at its current rate, TECSYS (TSX:TCS) shares could double or triple over the next three years, says Cantor Fitzgerald Canada analyst Justin Kew. On Thursday, TECSYS will report its Q3, 2015 results. Kew expects it will post EBITDA of $1.4 million on revenue of $14.2-million. Both numbers are in […]

For Bombardier, the light at the end of the tunnel might be a train

The Bombardier Zefiro has a top operating speed of between 250 km/h and 380 km/h.

For more than a month now, the news has been especially bad for Bombardier (TSX:BBD.B). Midway through January, shares of the iconic Canadian company, which has been under pressure since 2011, began a fall that would see its market cap nearly halved. The culprit was cash. Bombardier, warned analysts such as RBC’s Walter Spracklin, didn’t […]